These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22743351)

  • 1. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
    Morand R; Todesco L; Donzelli M; Fischer-Barnicol D; Mullen PJ; Krähenbühl S
    Ther Drug Monit; 2012 Aug; 34(4):406-14. PubMed ID: 22743351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis.
    Vernez L; Dickenmann M; Steiger J; Wenk M; Krähenbühl S
    Nephrol Dial Transplant; 2006 Feb; 21(2):450-8. PubMed ID: 16286428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
    Haschke M; Vitins T; Lüde S; Todesco L; Novakova K; Herrmann R; Krähenbühl S
    Nephrol Dial Transplant; 2010 Feb; 25(2):426-33. PubMed ID: 19736245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation.
    Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y
    J Child Neurol; 1992 Oct; 7(4):404-7. PubMed ID: 1469250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats.
    Schürch R; Todesco L; Novakova K; Mevissen M; Stieger B; Krähenbühl S
    Eur J Pharmacol; 2010 Jun; 635(1-3):171-6. PubMed ID: 20303936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.
    Todesco L; Bodmer M; Vonwil K; Häussinger D; Krähenbühl S
    Chem Biol Interact; 2009 Aug; 180(3):472-7. PubMed ID: 19539806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa.
    Kobayashi D; Tamai I; Sai Y; Yoshida K; Wakayama T; Kido Y; Nezu J; Iseki S; Tsuji A
    Reproduction; 2007 Nov; 134(5):651-8. PubMed ID: 17965255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carnitine, acetyl-, and propionylcarnitine supplementation on the body carnitine pool, skeletal muscle composition, and physical performance in mice.
    Morand R; Bouitbir J; Felser A; Hench J; Handschin C; Frank S; Krähenbühl S
    Eur J Nutr; 2014 Sep; 53(6):1313-25. PubMed ID: 24337254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1).
    Glube N; Closs E; Langguth P
    Mol Pharm; 2007; 4(1):160-8. PubMed ID: 17274673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of carnitine and carnitine precursors lysine, epsilon-N-trimethyllysine, and gamma-butyrobetaine in drug-induced carnitine depletion.
    Melegh B; Pap M; Bock I; Rebouche CJ
    Pediatr Res; 1993 Oct; 34(4):460-4. PubMed ID: 8255678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells.
    Kobayashi D; Irokawa M; Maeda T; Tsuji A; Tamai I
    Reproduction; 2005 Dec; 130(6):931-7. PubMed ID: 16322553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
    Kano T; Kato Y; Ito K; Ogihara T; Kubo Y; Tsuji A
    Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of OCTN2-mediated transport of carnitine by etoposide.
    Hu C; Lancaster CS; Zuo Z; Hu S; Chen Z; Rubnitz JE; Baker SD; Sparreboom A
    Mol Cancer Ther; 2012 Apr; 11(4):921-9. PubMed ID: 22389472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
    Wu X; Huang W; Prasad PD; Seth P; Rajan DP; Leibach FH; Chen J; Conway SJ; Ganapathy V
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1482-92. PubMed ID: 10454528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment.
    Ohnishi S; Okamura N; Sakamoto S; Hasegawa H; Norikura R; Kanaoka E; Takahashi K; Horie K; Sakamoto K; Baba T
    Drug Metab Pharmacokinet; 2008; 23(4):293-303. PubMed ID: 18762717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine and γ-Butyrobetaine Stimulate Elimination of Meldonium due to Competition for OCTN2-mediated Transport.
    Liepinsh E; Makarova E; Sevostjanovs E; Hartmane D; Cirule H; Zharkova-Malkova O; Grinberga S; Dambrova M
    Basic Clin Pharmacol Toxicol; 2017 May; 120(5):450-456. PubMed ID: 27983775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sports activity on carnitine metabolism. Measurement of free carnitine, gamma-butyrobetaine and acylcarnitines by tandem mass spectrometry.
    Inoue F; Terada N; Nakajima H; Okochi M; Kodo N; Kizaki Z; Kinugasa A; Sawada T
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):83-8. PubMed ID: 10491992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.